Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.
Gobaru M, Ashida K, Yoshinobu S, Nagayama A, Kabashima M, Iwata S, Hasuzawa N, Tsuruta M, Wada N, Nakayama H, Motomura S, Tajiri Y, Nomura M. Gobaru M, et al. Among authors: nagayama a. Am J Case Rep. 2019 Nov 20;20:1709-1714. doi: 10.12659/AJCR.918996. Am J Case Rep. 2019. PMID: 31745069 Free PMC article.
Pasireotide-induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist for treatment.
Shikata M, Ashida K, Goto Y, Nagayama A, Iwata S, Yano M, Hasuzawa N, Hara K, Mawatari K, Sakata K, Tsuruta M, Wada N, Nomura M. Shikata M, et al. Among authors: nagayama a. Clin Case Rep. 2020 Aug 13;8(12):2613-2618. doi: 10.1002/ccr3.3230. eCollection 2020 Dec. Clin Case Rep. 2020. PMID: 33363790 Free PMC article.
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
Nagayama A, Ashida K, Watanabe M, Moritaka K, Sonezaki A, Kitajima Y, Takahashi H, Yoshinobu S, Iwata S, Yasuda J, Hasuzawa N, Ozono S, Motomura S, Nomura M. Nagayama A, et al. Front Endocrinol (Lausanne). 2021 May 31;12:690996. doi: 10.3389/fendo.2021.690996. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34135866 Free PMC article.
An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing's Syndrome and Autonomous Cortisol Secretion.
Oda S, Ashida K, Uchiyama M, Sakamoto S, Hasuzawa N, Nagayama A, Wang L, Nagata H, Sakamoto R, Kishimoto J, Todaka K, Ogawa Y, Nakanishi Y, Nomura M. Oda S, et al. Among authors: nagayama a. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3865-e3880. doi: 10.1210/clinem/dgab450. J Clin Endocrinol Metab. 2021. PMID: 34143883 Clinical Trial.
134 results